Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
464,061
+105,599
+29% +$661K 0.01% 417
2025
Q4
$2.62M Buy
358,462
+76,012
+27% +$736K 0.01% 406
2025
Q3
$2.82M Sell
282,450
-134,739
-32% -$1.49M 0.01% 391
2025
Q2
$3.77M Buy
417,189
+138,168
+50% +$901K 0.02% 328
2025
Q1
$1.79M Buy
279,021
+20,614
+8% +$183K 0.01% 417
2024
Q4
$2.46M Buy
258,407
+20,949
+9% +$184K 0.01% 373
2024
Q3
$1.94M Buy
237,458
+7,635
+3% +$79.3K 0.01% 395
2024
Q2
$3.11M Buy
229,823
+10,888
+5% +$91K 0.02% 323
2024
Q1
$1.53M Buy
218,935
+176,804
+420% +$1.54M 0.01% 414
2023
Q4
$461K Buy
42,131
+19,640
+87% +$193K ﹤0.01% 590
2023
Q3
$247K Buy
22,491
+1,611
+8% +$23K ﹤0.01% 680
2023
Q2
$330K Buy
+20,880
New +$243K ﹤0.01% 621

Other funds holding ENVX

Scotia Capital's ENVX Position: Q1 2026 in Review

Scotia Capital increased its Enovix (ENVX) stake by 29% in Q1 2026, buying an estimated $661K and bringing the position to 464,061 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #417.

Scotia Capital first reported a position in ENVX in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.77M in Q2 2025. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Scotia Capital held 464,061 shares of Enovix worth $2.4M as of Q1 2026.
  • Scotia Capital bought 105,599 Enovix shares in Q1 2026, an estimated $661K.
  • Enovix made up 0.01% of Scotia Capital's portfolio in Q1 2026, its #417 holding.
  • Scotia Capital first reported a position in Enovix in Q2 2023 and has held it in 12 quarters since.
  • Scotia Capital's Enovix position peaked at $3.77M in Q2 2025.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.